Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate...
41 insider purchases on record · latest filing 2025-11-12.
Insiders have also filed 18 sale transactions at APVO.